Search
for
Sort by
Research 30 of 1000+
- 7472 Estrogen Monotherapy for Testosterone Suppression in Gender Diverse Patients
- 7472 Estrogen Monotherapy for Testosterone Suppression in Gender Diverse Patients
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor
- Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
- Synergistic effects of Rhynchosia nulubilis and Polygonum multiflorum extract combination on cell proliferation via targeting IGFBP-1 & NT-3 and cytotoxicity suppression in testosterone-induced human dermal papilla cells
- <i>Arachis hypogaea</i> L. Root Extract Mitigates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- The role of 5-α-reductase inhibition in supressing progression of male androgenetic alopecia − a postulate for further studies on possible application of saw palmetto extracts
- Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- Alleviation of Androgenetic Alopecia with Aqueous Paeonia lactiflora and Poria cocos Extract Intake through Suppressing the Steroid Hormone and Inflammatory Pathway
- Hallmark evidence of lipopolysaccharide (LPS) tolerance in obese women with polycystic ovary syndrome (PCOS) - LPS-induced NFkB suppression in mononuclear cells (MNC) is linked to hyperandrogenism in PCOS
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Safety and efficacy of topical minoxidil in the management of androgenetic alopecia
- Hormonal Treatment of Transgender Women with Oral Estradiol
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Influence of The Anabolic Steroid Usage on The Physical Health: A Review
- Health Complications Associated with Anabolic-Androgenic Steroid Use in Physically Active Men: A Literature Review
- REAL WORLD STUDY ON ORAL ESTRADIOL TREATMENT IN TRANSGENDER WOMEN
- SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- The Case of the Elusive Androgen
- Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Sex differences in COVID-19: the role of androgens in disease severity and progression